(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 0.7% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.11%.
Solventum's revenue in 2024 is $8,197,000,000.On average, 1 Wall Street analysts forecast SOLV's revenue for 2024 to be $1,406,005,788,976, with the lowest SOLV revenue forecast at $1,406,005,788,976, and the highest SOLV revenue forecast at $1,406,005,788,976. On average, 1 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,425,428,567,442, with the lowest SOLV revenue forecast at $1,425,428,567,442, and the highest SOLV revenue forecast at $1,425,428,567,442.
In 2026, SOLV is forecast to generate $1,469,641,956,842 in revenue, with the lowest revenue forecast at $1,469,641,956,842 and the highest revenue forecast at $1,469,641,956,842.